ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,304, issued on Nov. 18, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).

"Heterocyclic PAD4 inhibitors" was invented by Kumaravel Selvakumar (Bangalore, India), Venkatram Reddy Paidi (Kamareddy, India), Srinivasan Thangathirupathy (Hosur, India), Vijaya Kumar Cm (Hosur, India), Tirupathi Rao Alajangi (Vizianagaram, India), Mallikarjun Reddy Sura (Kadapa, India), Krishna Mahadevu (Mandya, India), Ramesh Kumar Sistla (Bangalore, India), Piyush Agarwal (Jodhpur, India), Arul Mozhi Subbiah Karuppiah (Bangalore, India), Jalathi S. Nair (Bangalore, India), Ooha Morampudi (Khammam, India), Manoranjan Panda (Bangalore, India), Joseph A. Tino (Lawrenceville, N.J.), Robert J. Che...